Journal Article Summary
The article investigates the management of a pregnant woman with acute severe ulcerative colitis (UC) who also contracted COVID-19. Understanding how to treat patients with inflammatory bowel disease during the COVID-19 pandemic is crucial, as these patients often require immunosuppressive therapies, which may complicate their care when facing an infectious disease. This situation is particularly concerning since there is limited evidence on how COVID-19 affects individuals with immune-mediated conditions, especially during pregnancy.
In the study, the authors presented a case of a pregnant woman in her first trimester diagnosed with acute severe UC who also tested positive for COVID-19. They reviewed her treatment approach along with existing literature related to pregnancy, inflammatory bowel disease, and COVID-19. Key findings highlighted the complexity of managing her condition, requiring careful consideration of the risks associated with both her underlying disease and the viral infection.
Despite the insights gained, the authors note several limitations, including the scarcity of data regarding the interaction between COVID-19 and inflammatory bowel disease during pregnancy. The case report emphasizes the importance of a tailored approach to treatment and the need for close monitoring. Patients and caregivers are encouraged to discuss their specific conditions and treatment options with healthcare professionals, especially in light of unique challenges presented by COVID-19.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Rosen Melissa H, Axelrad Jordan, Hudesman David, Rubin David T, Chang Shannon. Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature. Inflammatory Bowel Diseases 2020. DOI: 10.1093/ibd/izaa109. PMID: 32393973. PMCID: PMC7239163.
Featured Pill Pals Product
Cyclosporine Eye Drops 0.05% --- 0.4 ML --- Pack of 30 --- Generic For Restasis --- Apotex
Cyclosporine Eye Drops 0.05% --- 0.4 ML --- Pack of 30 --- Generic For Restasis --- Apotex is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
